Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Biol Reprod ; 62(4): 1047-51, 2000 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-10727276

RESUMO

To determine whether prostaglandin (PG) F(2alpha) had a dose-dependent effect upon secretion of progesterone, oligonucleosome formation, or loss of luteal weight, ewes on Day 9 or 10 of the estrous cycle were administered 0, 3, 10, or 30 mg PGF(2alpha) per 60 kg BW (i.v.), and luteal tissue was collected 9 and 24 h after injection. All doses of PGF(2alpha) decreased (P < 0. 05) concentrations of progesterone in sera by 9 h; however, in ewes treated with 3 mg PGF(2alpha), concentrations of progesterone were similar to control values at 24 h and higher (P < 0.05) than those in the 10- or 30-mg groups. Concentrations of progesterone in sera over all dose levels were highly correlated to luteal concentrations of mRNA encoding steroidogenic acute regulatory protein (P < 0.001), cytochrome P450 side-chain cleavage (P < 0.02), and 3beta-hydroxysteroid dehydrogenase (P < 0.01). Corpora lutea collected at 24 h from ewes treated with the 10- and 30-mg doses of PGF(2alpha) weighed less (P < 0.05) than those from controls. Oligonucleosomes were not present in luteal tissues from control ewes. Surprisingly, all doses of PGF(2alpha)-induced oligonucleosomes in a majority of animals at 9 h and in a majority of ewes treated with 10 and 30 mg of PGF(2alpha) at 24 h. In conclusion, 3 mg of PGF(2alpha) per 60 kg BW transiently decreased serum concentrations of progesterone and induced oligonucleosome formation, but did not result in reduced luteal weight. The 10- and 30-mg doses of PGF(2alpha) decreased secretion of progesterone and induced oligonucleosome formation and luteolysis.


Assuntos
Corpo Lúteo/metabolismo , Dinoprosta/farmacologia , Nucleossomos/metabolismo , Esteroides/biossíntese , 3-Hidroxiesteroide Desidrogenases/biossíntese , Animais , Corpo Lúteo/efeitos dos fármacos , Corpo Lúteo/ultraestrutura , DNA/análise , DNA/biossíntese , DNA/isolamento & purificação , Dinoprosta/biossíntese , Estro/fisiologia , Feminino , Luteólise/efeitos dos fármacos , Nucleossomos/efeitos dos fármacos , Nucleossomos/ultraestrutura , Tamanho do Órgão/efeitos dos fármacos , Fosfoproteínas/biossíntese , Progesterona/biossíntese , RNA Mensageiro/análise , RNA Mensageiro/biossíntese , Receptores do LH/biossíntese , Ovinos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA